Search

everythinglearnresearchcommunity

for

Search:↓

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Certain genes are linked to the risk of developing Alopecia Areata.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

CRISPR/Cas9 gene-editing may effectively treat hair loss but requires more research for safe use.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

A genetic marker linked to a type of hair loss was found in most patients studied.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Vitiligo causes white skin patches and can lead to psychological stress.

Two mouse mutations cause similar hair loss despite different skin changes.

Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.